New Study Highlights Value of Physiologically Relevant 3D InSight™ Liver Microtissues for Nanomaterial Safety Assessments
A new study, conducted as part of PATROLS, established InSphero 3D InSight™ Multi-Donor Human Liver Microtissues as a valuable nanotoxicology risk assessment tool.
The PATROLS project abstract by Hana Barosova was awarded the Student Research prize at ISAM 2019 (International Society for Aerosols in Medicine) in Montreux, Switzerland.
Article by Shareen Doak, Martina G.Vijver and Martin Clift published on THE CONVERSATION.
Listen to this short interview with Professor Shareen Doak of the University of Swansea.
The PATROLS project started in January 2018 and, through its consortium of 24 partners, has already achieved significant advances. This article reviews progress and outcomes in its first year and looks forward to 2019.
The 1st Annual Meeting of PATROLS was organised by ISTEC in Faenza, Italy.
The PATROLS project presents a 30 minutes webinar introducing the drivers behind the project, its scientific aims and potential impact.
On the 12th and 13th of June 2018, a joint workshop on harmonization of Standard Operating Procedures (SOPs) was held at RIVM, the Netherlands. This activity was part of the Nanosafety Cluster (Working Group C) and was sponsored by the EU projects PATROLS and GRACIOUS. It was organized to follow-up on the EU ProSafe ‘White Paper’ recommendation to come up with harmonised and validated test methods for nanomaterials to support regulatory risk assessment. Such SOPs are required to facilitate the generation of data that are reliable and comparable, and thus can be used and re-used for risk assessment and modelling the effects of nanomaterials.
The PATROLS project was in action at the Chemspec Europe, the international exhibition for speciality chemicals, hosted in Cologne on June 20-21. The Nanotechnology Industries Association (NIA) represented the project as the first stakeholder activity of the project, with the intention to engage industry stakeholders and understand their needs and challenges in the safe development of nanomaterials.
A new €12.7m global project led by Swansea University Medical School will address the need for safer and more effective testing of nanomaterials, an area that is of crucial and growing importance to billion-pound markets including cosmetics, electronics, medicine and food.